GERON ANNOUNCES LICENSE AGREEMENT WITH CAMBREX

Geron has announced a worldwide license agreement between Geron and Cambrex Bio Science Walkersville, under which the Cambrex subsidiary will develop and distribute cell lines that have been immortalized using Geron's proprietary telomerase technology. Under the terms of the nonexclusive agreement, Cambrex Bio Science will develop telomerized cell lines and associated products such as media.

Yahoo News (http://biz.yahoo.com/bw/050111/115341_1.html)